DERMA PHARM A/S — Credit Rating and Financial Key Figures

DERMA PHARM A/S (CVR number: 89453119) is a company from RANDERS. The company recorded a gross profit of 81.3 mDKK in 2023. The operating profit was 13.8 mDKK, while net earnings were 9574.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 11.2 %, which can be considered good but Return on Equity (ROE) was 22.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 37.4 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. DERMA PHARM A/S's liquidity measured by quick ratio was 0.5 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.